HCR ManorCare selects dialysis services
09/04/2026
Dialyze Direct has entered into a national cooperation agreement with HCR ManorCare to provide staff-assisted in-home hemodialysis services at HCR ManorCare’s ManorCare Health Services skilled nursing facilities across multiple states.
At each nursing home, Dialyze Direct will allow patients with end-stage renal disease to receive patient-centric dialysis treatments without leaving the facility. Dialyze Direct’s teams will work with ManorCare’s skilled nursing and rehab care staff.
“Our world renowned nephrology leadership team deploys the most advanced home dialysis technology to provide treatment that addresses the specific needs of elderly patients, SNFs, hospitals and payers,” said Josh Rothenberg, COO of Dialyze Direct. “Dialyze Direct’s patient-centric model of care focuses on significantly improving complex co-morbidities, and provides the best chance to reduce re-hospitalizations.”
Rather than have SNF patients leave the facility, ManorCare patients in the Dialyze Direct model can receive in-home care at their skilled nursing facility for approximately two-and-a-half hours. Recovery time for Dialyze Direct’s in-home dialysis treatment is typically around 30 to 60 minutes, versus eight to nine hours for traditional dialysis, which can escalate to an average of 21 hours for elderly patients, the company said.
“For end-stage renal disease patients, dialysis is a life-saving, yet incredibly taxing, medical treatment,” said Rami Ubaydi, vice president and general manager for HCR ManorCare.. “With Dialyze Direct’s in-home hemodialysis services, we are looking to change that for residents in our skilled nursing facilities. By eliminating the travel time, logistics and cost associated with transporting patients to outpatient facilities, while simultaneously improving the quality of dialysis care provided to our patients, our skilled nursing staff will be able to focus on providing quality care and allow our patients to continue their normal social and medical activities.”
Dr. Allen Kaufman is the Chief Medical Officer and Senior VP for Clinical & Scientific Affairs at Dialyze Direct, with over four decades of experience in Nephrology. He began his career in 1980 and has held leadership roles including Chief of Nephrology & Hypertension at Beth Israel Medical Center (1998–2004), Chief of Dialysis at the Bronx VA Medical Center (1982–1990), and Chief of the Yorkville Dialysis Unit at Beth Israel and the Renal Research Institute (1990–2000). Dr. Kaufman has authored over 100 scientific publications and served as Principal or Co-Investigator on numerous NIH-funded research studies. A Fellow of the American College of Physicians, he is board-certified in Nephrology and Internal Medicine. He earned his medical degree from the University of Rochester and completed training at the Hospital of the University of Pennsylvania and Mount Sinai in New York. Dr. Kaufman is widely recognized with multiple “Best Doctor” and “Patients’ Choice” awards.